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This paper is the first report from the Percutaneous Trans- 
luminal Coronary Angioplasty (PTCA) Registry of the 
National Heart, Lung, and Blood Institute (NHLBI). The 
era of interventional cardiology was born with the perfor- 
mance of the first successful balloon angioplasty by Andreas 
Gruentzig on September 16, 1977 (1). The background for 
this extraordinary accomplishment required the develop- 
ment of coronary arteriography, direct coronary bypass 
surgery and percutaneous peripheral vascular dilation. Gru- 
cntzig's wiUingness to teach the technique in its earliest 
rudimentary form to all who would come to Zurich was 
~fided by the first set of disciples, including Myler, Stertzer, 
Kaltenbach and others. By 1979, a small number of cases 
had been accumulated, and the companies manufacturing 
the devices continued to control the proliferation of the 
technique by releasing catheters only to those physicians 
who had visited and observed Gruentzig at work. As more 
operators began to perform angioplasty in the U.S., it 
became vident hat a more organized evaluation of this 
fledgling technology could be of great value. After a con- 
versation with Gruentzig and others, Dr. Michael Mook of 
the NHLBI  was instrumental in convening a workshop in 
June 1979 at the Institute headquarters in Bethesda, Mary- 
land. The outcome of that workshop was the formation of 
an international registry of PTCA patients that would 
provide a meaningful evaluation of this new procedure (2). 
An initial report from the accumulated experience was 
presented at that workshop, and virtually all of the early 
practitioners of angioplasty joined that registry. 
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ABSTRACT 
Data have been collected from 34 centers in the United States 
and Europe performing percutaneous transluminal coronary 
angioplasty since September 1977. The procedure was carried 
out in 631 patients, with an average age of 51 years (range 23 
to 76), of whom 80percent had single vessel coronary disease, 17 
percent had double or triple vessel disease and 3 percent had 
50th Anniversary Historical Article 
INTRODUCTION 
In this edition of the Journal, we release the tenth in a series of 
reviews of influential articles that have been previously pub- 
fished in ACC journals, including the American Journal of Cardi- 
ology (from 1958 to 1982) andJACC (from 1983 to the present). 
The publication of these articles i only one aspect of the ACC's 
50th anniversary commemoration, which highlights 50 years of 
leadership n cardiovascular c re and education. The articles axe 
intended to encourage r flection on the remarkable progress made 
in cardiovascular medicine over time, as well as to acknowledge the 
amazing prescience of some arly investigators in anticipating and, 
in many cases, later guiding developments in their field. 
The working group responsible for selecting these articles and 
asking reviewers to write editorials olicited suggestions from 
the ACC's clinical committees and individual members. 
The group achieved consensus fairly easily, including whom the 
group should ask to prepare the accompanying editorials. We 
initially drew up a list of 14 general areas to cover in this series, 
but later found that there are several major areas of modem 
cardiology, prominently molecular cardiology, inwhich the truly 
landmark articles have, alas, not yet been published in JACC. 
Therefore, the working roup decided not to categorize bysubject, 
but instead, to concentrate onthe most important articles. 
The working group, a task force of the Subcommittee for the 
Commemoration fthe ACC 50th Anniversary, owes a great 
deal to Ms. May A. Roustom and the efficient and tireless taff 
at Heart House for facilitating this project. We also wish to 
thank all who suggested articles and, most important, the 
authors who prepared reviews for their willingness to contribute 
their time and wisdom. 
Influential Articles in JACC Working Group 
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stenosis of the lqq mahz coronary.artery. Coronary angioplasty was 
successful (greater than 20 percent deo'ease of coronary stenosis) in 
59 percent of the stenosed arteries. The mean degree of stenosis was 
reduced from 83 to 31 percent. Emergency coronary bypass opera- 
tion was required in 40 patients (6 percent). Myocardial infarction 
occurred in 29patients (4percent). In-hospital death occun'ed insix 
patients (1 percent), three with single vessel and three with 
multivessel disease. Ninely-one patients have been followed up for 
at least 1 year after coronary ang~oplasty. Oft& 65 patients with 
an initially succesful angioplasty, 83 percent were in improved 
condition compared with their status before angioplasty. Thus, the 
initial satisfactory esults obtained in a few centers have now been 
confirmed in ,natty centers using lransluminal coronary ang~o- 
plasty. 
Originally pubfished in the Journal of the .,hnc~qcan College of Cardiology, June 
1982. 
Revle~o 
This first report from 34 centers in the U.S. and Europe had 
traced their entire experience with angioplasty. The kind of 
patients treated reflected Gruentzig's initial recommenda- 
tions in that 800/6 had single-vessel disease. With the 
primitive equipment available, 59% had successful dilation. 
The complication rates, including emergency operations, 
myocardial infarction and death, reflected a careful selection 
of patients, and the first one-year follow-up documented 
symptomatic improvement. 
The NHLBI PTCA Registry was pivotal in the devel- 
opment of interventional cardiology, as it showed for the 
first time that Gruentzig's experimental procedure could be 
applied to a broader ange of patients by multiple operators. 
The spirit of collegiality and cooperative assessment of the 
technique in its early days was perhaps unique. Many of the 
original investigators ofballoon angioplasty have continued 
to cooperate with the registry, which was moved to the 
School of Public Health at the University of Pittsburgh 
under the organizational structure of Dr. Katherine Detre. 
A subsequent registry was instituted after balloon angio- 
plasty had achieved amore mature status. Patient data were 
collected in 1985 and 1986 by the NHLBI Registry partic- 
ipants, and these data have been compared with the earlier 
period (3). Improvements were documented after important 
technologic advances, including, especially, the develop- 
ment in 1982 of steerable guide wires. 
The value of prospectively collected registry data has 
perhaps been underappreciated in this era of large targeted 
randomized trials, but these data were essential for under- 
standing the baseline features of patients undergoing angio- 
plasty and their outcomes. This registry, in fact, set the stage 
for development ofrandomized trials. Much of the planning 
and structure of the Emory Angioplasty versus Surgery Trial 
(4) and the Bypass Angioplasty Revascularization Investi- 
gation (5), both sponsored by the NHLBI, were based on 
data generated from the NHLBI PTCA Registries. As new 
devices began to be developed in the late 1980s, another 
registry, the New Approaches to Coronary Interventions 
(NACI) Registry, was developed. It has been possible to 
compare the use and outcome of many of these new devices 
with the NHLBI Registries and to structure clinical trials to 
investigate those devices (6). More recently, the registry has 
evolved into the Dynamic Registry of Percutaneous Coronary 
Interventions. During defined collection periods, the partici- 
pating NHLBI sites enter all patients into a defined atabase. 
By doing so, a snapshot of interventional cardiology practice 
can be generated to reflect changes in practice patterns and 
outcomes. The last two registry collection periods in 1997/ 
1998 and in 1999 show continuing evolution of the method 
with increased utilization of stenting with concombinant im- 
provement in acute complication rates. These registries will 
also enable assessment of long-term outcomes based on meth- 
odologic hanges and in subgroups of great interest induding 
gender, racial and ethnic differences and disease state differ- 
ences, especially for the diabetic population. In addition to 
identifying current practice results, the registries will stimulate 
questions that need further andomized trials. In fact, many of 
the ongoing trials, including stent trials (Stent or Surgery, 
ARTS trial) and angioplasty versus medical treatment trials 
(Veterans Affairs Non-QzWave Infarction Strategies in Hos- 
pital study [VANQWISH], Coronary angioplasty versus med- 
ical therapy for angina [RITA-2], Fragmin during Instability 
in Coronary artery disease [FRISC II], planned Bypass An- 
gioplasty Revascularization I vestigation [BAR/II], Clinical 
Outcomes Utilizing Revascularization and Aggressive Drug 
Evaluation [COURAGE], and Study of Coronary Revascu- 
larization And Therapeutics Evaluations [SOCRATES]), all 
gained valuable data from understanding the registry restdts. 
These registries also have the potential to serve an important 
postmarketing surveillance function. Currently, new devices 
must undergo some comparative evaluation before approval by 
the Food and Drug Administration (FDA), but these evalua- 
tions are made on the basis of a carefully defined population of 
patients. The real-world use of devices cannot be adequately 
assessed by either the FDA or the device manufacturers 
because once the device is approved, its utilization is broadened 
by practitioners. The registry has the potential to collect 
unselected data that will include the utilization of these new 
devices and may detect problematic indications or provide data 
that can enable broader labeling of these devices. It is impor- 
tant to understand what new devices are doing in actual 
practice in addition to what they did in a controlled preclinical 
evaluation. 
The NHLBI PTCA Registries have resulted in 45 
peer-reviewed articles in the medical iterature, including 
the long-term efficacy of PTCA (7), the comparison of 
changes in interventional technology (3), the incidence and 
consequence of occlusion of coronary arteries (8), the 
outcome of coronary angioplasty in women (9), the cause of 
death in late-term follow-up of patients undergoing angio- 
plasty (10) and the comparison of balloon angioplasty with 
new late-developing technologies (6). According to the 
Science Citation Index, publications from the NHLBI 
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Registries were cited a total of 3,757 times by February 
1996. Obviously, these registries have been important in the 
development of  interventional cardiology, and the use of  
such registries has been adopted by others in an attempt o 
evaluate the outcome of procedures and disease states. 
hnportant examples are the New York State Registry (11) 
and the National Cardiovascular Data Registry TM of the 
American College of  Cardiology. 
CONCLUSION 
The forward-thinking pioneers ofinterventional cardiology 
and the leadership of the NHLBI  and the Data Center at 
the University of  Pittsburgh are to be congratulated for both 
their foresight and persistence. The founding of the initial 
registry formed the basis of this communication, and the 
continuity of registry activity through the years has enabled 
,tn assessment of the dynamic nature of interventional 
,ardiology. Twenty-two years since the first coronary an- 
g~oplasty by Andreas Gruentzig, these techniques have 
evolved into an entire subspecialty discipline now recog- 
nized by its own board or certificate of added qualification 
from the American Board of Internal Medicine and have 
defined residency programs approved by the Accrediting 
Council on Graduate Medical Education. This first report 
or outcomes of the NHLBI  PTCA Registry established the 
tradition of  collaborative openness in assessing results that 
L;ruentzig espoused so vigorously. This objective, unbiased 
.L,sessment of  ongoing outcomes in interventional cardiol- 
,~,~y will remain an important part of his legacy. 
Reprint requests and correspondence: Dr. Spencer B. King III, 
Emory University Hospital, F606, 1364 Clifton Road, Atlanta, 
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